Home > Qtrly Results > ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES
Quarterly Results Analysis [Mar2026]

ZYDUS LIFESCIENCES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for ZYDUS LIFESCIENCES
Please provide your vote to see the results

ZYDUS LIFESCIENCES Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹7,587 Cr ₹6,865 Cr ₹6,123 Cr ₹6,574 Cr ₹6,528 Cr ₹5,269 Cr ₹5,237 Cr ₹6,208 Cr
Expenses ₹5,678 Cr ₹5,048 Cr ₹4,522 Cr ₹4,542 Cr ₹4,402 Cr ₹3,882 Cr ₹3,821 Cr ₹4,124 Cr
Operating Income ₹1,910 Cr ₹1,816 Cr ₹1,602 Cr ₹2,031 Cr ₹2,126 Cr ₹1,388 Cr ₹1,416 Cr ₹2,084 Cr
Other Income ₹779 Cr ₹111 Cr ₹523 Cr ₹212 Cr ₹81 Cr ₹58 Cr ₹114 Cr ₹63 Cr
Interest ₹123 Cr ₹130 Cr ₹101 Cr ₹85 Cr ₹77 Cr ₹32 Cr ₹25 Cr ₹32 Cr
Depreciation ₹508 Cr ₹360 Cr ₹302 Cr ₹238 Cr ₹238 Cr ₹229 Cr ₹234 Cr ₹215 Cr
Profit Before Tax ₹1,660 Cr ₹1,353 Cr ₹1,687 Cr ₹1,921 Cr ₹1,672 Cr ₹1,184 Cr ₹1,271 Cr ₹1,900 Cr
Profit After Tax ₹1,341 Cr ₹965 Cr ₹1,233 Cr ₹1,487 Cr ₹1,249 Cr ₹1,005 Cr ₹898 Cr ₹1,464 Cr
EPS ₹12.65 ₹10.36 ₹12.51 ₹14.58 ₹11.64 ₹10.17 ₹9.06 ₹14.11
Industry Peers & Returns1W1M1Y
ZYDUS LIFESCIENCES 4.8% 11.8% 13.7%
SUN PHARMACEUTICAL INDUSTRIES -3.2% 10.5% 9.3%
DIVIS LABORATORIES 0.8% 9.5% 4.2%
TORRENT PHARMACEUTICALS 2% 9.9% 35.4%
CIPLA -1.9% 13.3% -6%
DR REDDYS LABORATORIES -1.8% 7.4% 8.2%
MANKIND PHARMA -0.6% 11% -1.8%
LUPIN 1.2% -1.2% 12.7%
AUROBINDO PHARMA -2.5% 3.1% 28.2%

ZYDUS LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

10.53 %

Y-o-Y

16.22 %

Quarters Revenues % Change
Mar2026 ₹7,587 Cr
10.53
Dec2025 ₹6,865 Cr
12.11
Sep2025 ₹6,123 Cr
-6.85
Jun2025 ₹6,574 Cr
0.70
Mar2025 ₹6,528 Cr
23.89
Dec2024 ₹5,269 Cr
0.61
Sep2024 ₹5,237 Cr
-15.63
Jun2024 ₹6,208 Cr -

ZYDUS LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

5.13 %

Y-o-Y

-10.16 %

Quarters Operating Profit % Change
Mar2026 ₹1,910 Cr
5.13
Dec2025 ₹1,816 Cr
13.40
Sep2025 ₹1,602 Cr
-21.15
Jun2025 ₹2,031 Cr
-4.43
Mar2025 ₹2,126 Cr
53.18
Dec2024 ₹1,388 Cr
-2.01
Sep2024 ₹1,416 Cr
-32.05
Jun2024 ₹2,084 Cr -
Operating Margins
Q-o-Q

-4.88 %

Y-o-Y

-22.70 %

Quarters Operating Margin% % Change
Mar2026 25.17%
-4.88
Dec2025 26.46%
1.15
Sep2025 26.16%
-15.34
Jun2025 30.9%
-5.10
Mar2025 32.56%
23.66
Dec2024 26.33%
-2.63
Sep2024 27.04%
-19.45
Jun2024 33.57% -

ZYDUS LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

38.98 %

Y-o-Y

7.41 %

Quarters Profit After Tax % Change
Mar2026 ₹1,341 Cr
38.98
Dec2025 ₹965 Cr
-21.75
Sep2025 ₹1,233 Cr
-17.03
Jun2025 ₹1,487 Cr
19.04
Mar2025 ₹1,249 Cr
24.31
Dec2024 ₹1,005 Cr
11.90
Sep2024 ₹898 Cr
-38.66
Jun2024 ₹1,464 Cr -
PAT Margins
Q-o-Q

25.75 %

Y-o-Y

-7.58 %

Quarters PAT Margin(%) % Change
Mar2026 17.68 %
25.75
Dec2025 14.06 %
-30.19
Sep2025 20.14 %
-10.92
Jun2025 22.61 %
18.19
Mar2025 19.13 %
0.31
Dec2024 19.07 %
11.26
Sep2024 17.14 %
-27.31
Jun2024 23.58 % -

ZYDUS LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

22.10 %

Y-o-Y

8.68 %

Quarters EPS % Change
Mar2026 ₹12.65
22.10
Dec2025 ₹10.36
-17.19
Sep2025 ₹12.51
-14.20
Jun2025 ₹14.58
25.26
Mar2025 ₹11.64
14.45
Dec2024 ₹10.17
12.25
Sep2024 ₹9.06
-35.79
Jun2024 ₹14.11 -

You may also like the below Video Courses